International Business Establishment

International Business Establishment Co. (IBE Pharma) is a pharmaceutical and nutraceutical company headquartered in Cairo, Egypt. The company specializes in the development, manufacturing, and distribution of herbal-based therapeutics and dietary supplements, with a strong focus on hepatoprotective and metabolic health. Its flagship product, BioPropolis, is a bee-derived resin utilized for its antimicrobial and anti-inflammatory properties, and it has been clinically studied for its role in managing glycemic control in type 2 diabetes and treating chronic periodontitis. IBE Pharma also markets liver-support products such as Legalon (silymarin) and Alpha Hepadox, targeting conditions like non-alcoholic fatty liver disease (NAFLD) and cirrhosis. The company operates in collaboration with its sister manufacturing entity, Thita Pharmaceutical Industries, and utilizes contract manufacturing partnerships to serve the Egyptian and regional markets.